Literature DB >> 6448821

Effect of fusidic acid on the immune response in mice.

A Bellahsène, A Forsgren.   

Abstract

The effect of fusidic acid on the immune response in mice was studied. At the nontoxic dose of 500 mg/kg per day, the cell-mediated immunity was strongly inhibited. A marked and significant prolonged survival of split-heart allografts in treated animals was detected. The survival time of allografts in mice receiving fusidic acid from the day of the transplantation until the grafts were rejected was 26.1 days compared with 14.5 days in untreated animals. In mice treated also before the transplantation, the mean survival of the allografts were even longer. The phytohemagglutinin response, as well as the mixed lymphocyte culture stimulation of spleen lymphocytes from mice given 500 mg of fusidic acid per kg daily for 1 week, were significantly inhibited. At the same dose there was also a significantly decreased primary antibody response to sheep erythrocytes, but it was of limited biological significance. The immunosuppressive effect in animals treated with a human therapeutic dose of fusidic acid (25 mg/kg per day) was less pronounced but significant. The relevance of these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448821      PMCID: PMC551211          DOI: 10.1128/iai.29.3.873-878.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  METABOLIC EFFECTS OF THE STEROID ANTIBIOTIC FUSIDIC ACID.

Authors:  V WYNN
Journal:  Br Med J       Date:  1965-05-29

2.  Rat mixed lymphocyte culture: optimization of culture conditions.

Authors:  A Nemlander; L C Andersson; P Häyry
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

3.  Cardiac transplantation in mice. I. Factors influencing the take and survival of heterotopic grafts.

Authors:  K P Judd; J J Trentin
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

4.  Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay.

Authors:  A S Fauci; K R Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

5.  Depletion of monocytes from human peripheral blood mononuclear leukocytes: comparison of the sephadex G-10 column method with other commonly used techniques.

Authors:  T R Jerrells; J H Dean; G L Richardson; R B Herberman
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Effect of rifampin on the immune response in mice.

Authors:  A Bellahsène; A Forsgren
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

7.  Lymphocyte stimulation by protein A of Staphylococcus aureus.

Authors:  A Forsgren; A Svedjelund; H Wigzell
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

8.  Interaction of albumin and fusidic acid.

Authors:  F Güttler; L Tybring; H Engberg-Pedersen
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  Fusidic acid: inhibition of factor T2 in reticulocyte protein synthesis.

Authors:  M Malkin; F Lipmann
Journal:  Science       Date:  1969-04-04       Impact factor: 47.728

10.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

View more
  5 in total

1.  Clinical trial of fusidic acid for lepromatous leprosy.

Authors:  S G Franzblau; G P Chan; B G Garcia-Ignacio; V E Chavez; J B Livelo; C L Jimenez; M L Parrilla; R F Calvo; D L Williams; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

2.  Targeting PRPK Function Blocks Colon Cancer Metastasis.

Authors:  Tatyana Zykova; Feng Zhu; Lei Wang; Haitao Li; Do Young Lim; Ke Yao; Eunmiri Roh; Sang-Pil Yoon; Hong-Gyum Kim; Ki Beom Bae; Weihong Wen; Seung Ho Shin; Janos Nadas; Yan Li; Weiya Ma; Ann M Bode; Zigang Dong
Journal:  Mol Cancer Ther       Date:  2018-02-26       Impact factor: 6.261

3.  Quinolones affect thymidine incorporation into the DNA of human lymphocytes.

Authors:  A Forsgren; A K Bergh; M Brandt; G Hansson
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

4.  Fusidic acid is an effective treatment against Toxoplasma gondii and Listeria monocytogenes in vitro, but not in mice.

Authors:  Amanda J Payne; Lori M Neal; Laura J Knoll
Journal:  Parasitol Res       Date:  2013-08-16       Impact factor: 2.289

5.  Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.

Authors:  Bing Fan; Jie Guan; Xiumei Wang; Yulong Cong
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.